þ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Delaware | 76-0336636 | |
(State or other jurisdiction of | (IRS Employer | |
incorporation or organization) | Identification No.) | |
13403 Northwest Freeway, Houston, Texas | 77040-6094 | |
(Address of principal executive offices) | (Zip Code) |
Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o | Smaller reporting company o | |||
(Do not check if a smaller reporting company) |
Page | ||||||||
Part I. FINANCIAL INFORMATION |
||||||||
Item 1. Financial Statements |
||||||||
5 | ||||||||
6 | ||||||||
7 | ||||||||
8 | ||||||||
9 | ||||||||
22 | ||||||||
33 | ||||||||
33 | ||||||||
34 | ||||||||
35 | ||||||||
35 | ||||||||
35 | ||||||||
36 | ||||||||
36 | ||||||||
37 | ||||||||
Certification by CEO | ||||||||
Certification by CFO | ||||||||
Certification with Respect to Quarterly Report |
2
| the effects of catastrophic losses; | ||
| the cyclical nature of the insurance business; | ||
| inherent uncertainties in the loss estimation process, which can adversely impact the adequacy of loss reserves; | ||
| the effects of emerging claim and coverage issues; | ||
| the effects of extensive governmental regulation of the insurance industry; | ||
| potential credit risk with brokers; | ||
| our assessment of underwriting risk; | ||
| our increased retention of risk, which could expose us to greater potential losses; | ||
| the adequacy of reinsurance protection; | ||
| the ability or willingness of reinsurers to pay balances due us; | ||
| the occurrence of terrorist activities; | ||
| our ability to maintain our competitive position; | ||
| changes in our assigned financial strength ratings; | ||
| our ability to raise capital in the future; | ||
| attraction and retention of qualified employees; | ||
| fluctuations in securities markets, which may reduce the value of our investment assets; | ||
| our ability to successfully expand our business through the acquisition of insurance-related companies; | ||
| impairment of goodwill; | ||
| the ability of our insurance company subsidiaries to pay dividends in needed amounts; | ||
| fluctuations in foreign exchange rates; | ||
| failures of our information technology systems; and | ||
| change of control. |
3
4
June 30, | December 31, | |||||||
2008 | 2007 | |||||||
ASSETS |
||||||||
Investments: |
||||||||
Fixed income securities, at fair value (amortized cost: 2008 - $4,102,100; 2007 - $3,641,667) |
$ | 4,068,023 | $ | 3,666,705 | ||||
Short-term investments, at cost, which approximates fair value |
527,086 | 783,650 | ||||||
Other investments |
167,418 | 221,922 | ||||||
Total investments |
4,762,527 | 4,672,277 | ||||||
Cash |
27,129 | 39,135 | ||||||
Restricted cash and cash investments |
188,862 | 193,151 | ||||||
Premium, claims and other receivables |
810,109 | 763,401 | ||||||
Reinsurance recoverables |
1,030,408 | 956,665 | ||||||
Ceded unearned premium |
235,632 | 244,684 | ||||||
Ceded life and annuity benefits |
65,275 | 66,199 | ||||||
Deferred policy acquisition costs |
200,576 | 192,773 | ||||||
Goodwill |
818,329 | 776,046 | ||||||
Other assets |
176,431 | 170,314 | ||||||
Total assets |
$ | 8,315,278 | $ | 8,074,645 | ||||
LIABILITIES |
||||||||
Loss and loss adjustment expense payable |
$ | 3,446,824 | $ | 3,227,080 | ||||
Life and annuity policy benefits |
65,275 | 66,199 | ||||||
Reinsurance balances payable |
119,893 | 129,838 | ||||||
Unearned premium |
998,922 | 943,946 | ||||||
Deferred ceding commissions |
60,891 | 68,968 | ||||||
Premium and claims payable |
422,068 | 497,974 | ||||||
Notes payable |
369,714 | 324,714 | ||||||
Accounts payable and accrued liabilities |
267,272 | 375,561 | ||||||
Total liabilities |
5,750,859 | 5,634,280 | ||||||
SHAREHOLDERS EQUITY |
||||||||
Common stock, $1.00 par value; 250.0 million shares authorized (shares issued: 2008 - 115,701;
2007 - 115,069 and outstanding: 2008 - 115,581; 2007 - 115,069) |
115,701 | 115,069 | ||||||
Additional paid-in capital |
847,452 | 831,419 | ||||||
Retained earnings |
1,594,030 | 1,445,995 | ||||||
Accumulated other comprehensive income |
9,819 | 47,882 | ||||||
Treasury stock, at cost (shares: 2008 - 120) |
(2,583 | ) | | |||||
Total shareholders equity |
2,564,419 | 2,440,365 | ||||||
Total liabilities and shareholders equity |
$ | 8,315,278 | $ | 8,074,645 | ||||
5
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
REVENUE |
||||||||||||||||
Net earned premium |
$ | 1,000,156 | $ | 991,986 | $ | 506,610 | $ | 494,386 | ||||||||
Fee and commission income |
61,763 | 63,261 | 30,764 | 31,136 | ||||||||||||
Net investment income |
94,870 | 98,164 | 47,249 | 48,697 | ||||||||||||
Net realized investment loss |
(1,552 | ) | (624 | ) | (1,720 | ) | (69 | ) | ||||||||
Other operating income |
6,001 | 38,685 | 10,947 | 20,100 | ||||||||||||
Total revenue |
1,161,238 | 1,191,472 | 593,850 | 594,250 | ||||||||||||
EXPENSE |
||||||||||||||||
Loss and loss adjustment expense, net |
595,927 | 603,763 | 302,901 | 303,291 | ||||||||||||
Policy acquisition costs, net |
188,113 | 174,527 | 95,845 | 85,428 | ||||||||||||
Other operating expense |
116,718 | 111,108 | 57,514 | 53,467 | ||||||||||||
Interest expense |
7,767 | 4,399 | 3,808 | 1,096 | ||||||||||||
Total expense |
908,525 | 893,797 | 460,068 | 443,282 | ||||||||||||
Earnings before income tax expense |
252,713 | 297,675 | 133,782 | 150,968 | ||||||||||||
Income tax expense |
79,275 | 99,813 | 41,445 | 49,796 | ||||||||||||
Net earnings |
$ | 173,438 | $ | 197,862 | $ | 92,337 | $ | 101,172 | ||||||||
Basic earnings per share data: |
||||||||||||||||
Net earnings per share |
$ | 1.50 | $ | 1.76 | $ | 0.80 | $ | 0.90 | ||||||||
Weighted average shares outstanding |
115,363 | 112,117 | 115,492 | 112,273 | ||||||||||||
Diluted earnings per share data: |
||||||||||||||||
Net earnings per share |
$ | 1.49 | $ | 1.69 | $ | 0.80 | $ | 0.86 | ||||||||
Weighted average shares outstanding |
116,218 | 117,381 | 116,075 | 117,728 | ||||||||||||
Cash dividends declared, per share |
$ | 0.22 | $ | 0.20 | $ | 0.11 | $ | 0.10 | ||||||||
6
Accumulated | ||||||||||||||||||||||||
Additional | other | Total | ||||||||||||||||||||||
Common | paid-in | Retained | comprehensive | Treasury | shareholders | |||||||||||||||||||
stock | capital | earnings | income | stock | equity | |||||||||||||||||||
Balance at December 31, 2007 |
$ | 115,069 | $ | 831,419 | $ | 1,445,995 | $ | 47,882 | $ | | $ | 2,440,365 | ||||||||||||
Net earnings |
| | 173,438 | | | 173,438 | ||||||||||||||||||
Other comprehensive loss |
| | | (38,063 | ) | | (38,063 | ) | ||||||||||||||||
Comprehensive income |
135,375 | |||||||||||||||||||||||
Issuance of 546 shares for exercise of options,
including tax benefit of $599 |
546 | 9,322 | | | | 9,868 | ||||||||||||||||||
Stock-based compensation |
86 | 6,711 | | | | 6,797 | ||||||||||||||||||
Purchase of 120 treasury shares |
| | | | (2,583 | ) | (2,583 | ) | ||||||||||||||||
Cash dividends declared, $0.22 per share |
| | (25,403 | ) | | | (25,403 | ) | ||||||||||||||||
Balance at June 30, 2008 |
$ | 115,701 | $ | 847,452 | $ | 1,594,030 | $ | 9,819 | $ | (2,583 | ) | $ | 2,564,419 | |||||||||||
7
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net earnings |
$ | 173,438 | $ | 197,862 | $ | 92,337 | $ | 101,172 | ||||||||
Adjustments to reconcile net earnings to net cash provided
by operating activities: |
||||||||||||||||
Change in premium, claims and other receivables |
(43,624 | ) | 30,041 | (47,403 | ) | (57,125 | ) | |||||||||
Change in reinsurance recoverables |
(73,812 | ) | 94,621 | (76,483 | ) | (16,646 | ) | |||||||||
Change in ceded unearned premium |
9,052 | (21,249 | ) | (10,847 | ) | (23,139 | ) | |||||||||
Change in loss and loss adjustment expense payable |
219,858 | 105,937 | 128,013 | 89,492 | ||||||||||||
Change in reinsurance balances payable |
(9,945 | ) | (873 | ) | (4,184 | ) | 7,452 | |||||||||
Change in unearned premium |
55,022 | 62,882 | 71,982 | 65,504 | ||||||||||||
Change in premium and claims payable, net of
restricted cash |
(73,868 | ) | (42,100 | ) | (28,419 | ) | 44,587 | |||||||||
Change in current income taxes payable |
(7,310 | ) | (14,690 | ) | (42,975 | ) | (38,013 | ) | ||||||||
Change in trading portfolio |
42,574 | 4,865 | 33,512 | (6,093 | ) | |||||||||||
Gain on sales of strategic investments |
(9,158 | ) | (21,618 | ) | (9,158 | ) | (10,811 | ) | ||||||||
Stock-based compensation expense |
6,797 | 6,389 | 3,931 | 4,178 | ||||||||||||
Depreciation and amortization expense |
6,824 | 7,861 | 3,434 | 4,125 | ||||||||||||
Other, net |
(65,409 | ) | (9,628 | ) | (19,101 | ) | 5,306 | |||||||||
Cash provided by operating activities |
230,439 | 400,300 | 94,639 | 169,989 | ||||||||||||
Cash flows from investing activities: |
||||||||||||||||
Sales of fixed income securities |
236,878 | 174,718 | 116,803 | 146,235 | ||||||||||||
Maturity or call of fixed income securities |
182,410 | 158,121 | 106,535 | 87,973 | ||||||||||||
Cost of securities acquired |
(925,693 | ) | (736,873 | ) | (469,720 | ) | (369,678 | ) | ||||||||
Change in short-term investments |
256,564 | (26,014 | ) | 128,512 | (50,871 | ) | ||||||||||
Proceeds from sales of other investments |
30,994 | | 11,956 | | ||||||||||||
Proceeds from sales of strategic investments |
22,818 | 39,816 | 22,818 | 16,866 | ||||||||||||
Payments for purchase of subsidiaries, net of cash received |
(72,369 | ) | (51,681 | ) | (883 | ) | (45,764 | ) | ||||||||
Other, net |
(4,685 | ) | (5,356 | ) | (3,015 | ) | (3,188 | ) | ||||||||
Cash used by investing activities |
(273,083 | ) | (447,269 | ) | (86,994 | ) | (218,427 | ) | ||||||||
Cash flows from financing activities: |
||||||||||||||||
Advances on line of credit |
75,000 | 62,000 | 35,000 | 51,000 | ||||||||||||
Payments on line of credit and notes payable |
(30,000 | ) | (12,887 | ) | (30,000 | ) | (1,548 | ) | ||||||||
Sales of common stock |
9,868 | 16,422 | 5,276 | 8,382 | ||||||||||||
Dividends paid |
(25,340 | ) | (22,381 | ) | (12,682 | ) | (11,208 | ) | ||||||||
Other, net |
1,110 | (2,544 | ) | (2,798 | ) | 1,251 | ||||||||||
Cash provided (used) by financing activities |
30,638 | 40,610 | (5,204 | ) | 47,877 | |||||||||||
Net increase (decrease) in cash |
(12,006 | ) | (6,359 | ) | 2,441 | (561 | ) | |||||||||
Cash at beginning of period |
39,135 | 48,290 | 24,688 | 42,492 | ||||||||||||
Cash at end of period |
$ | 27,129 | $ | 41,931 | $ | 27,129 | $ | 41,931 | ||||||||
8
(1) | GENERAL INFORMATION | |
HCC Insurance Holdings, Inc. and its subsidiaries (collectively, the Company, we, us or our) include domestic and foreign property and casualty and life insurance companies, underwriting agencies and reinsurance brokers. We provide specialized property and casualty, surety, and group life, accident and health insurance coverages and related agency and reinsurance brokerage services to commercial customers and individuals. We market our products both directly to customers and through a network of independent and affiliated brokers, producers, agents and third party administrators. Our lines of business include diversified financial products (which includes directors and officers liability, professional indemnity, employment practices liability, surety and credit); group life, accident and health; aviation; our London market account (which includes energy, marine, property, and accident and health); and other specialty lines of insurance. We operate primarily in the United States, the United Kingdom, Spain, Bermuda, Belgium and Ireland, although some of our operations have a broader international scope. | ||
Basis of Presentation | ||
Our unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (generally accepted accounting principles) and include the accounts of HCC Insurance Holdings, Inc. and its subsidiaries. We have made all adjustments that, in our opinion, are necessary for a fair statement of results of the interim periods, and all such adjustments are of a normal recurring nature. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements should be read in conjunction with our annual audited consolidated financial statements and related notes. The condensed consolidated balance sheet at December 31, 2007 was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles. | ||
Management must make estimates and assumptions that affect amounts reported in our condensed consolidated financial statements and in disclosures of contingent assets and liabilities. Ultimate results could differ from those estimates. | ||
Significant Accounting and Reporting Policies | ||
We reported Significant Accounting and Reporting Policies in our Annual Report on Form 10-K for the year ended December 31, 2007. The following is a new disclosure related to Reinsurance. | ||
One assumed mortgage guaranty reinsurance contract, which is deemed not to transfer significant underwriting risk, is accounted for using the deposit method of accounting. In catastrophic or unforeseen circumstances, it is possible we could incur financial losses on this contract. We record all consideration received under the contract as a deposit liability, rather than as net earned premium and loss and loss adjustment expense. We use actuarial information to estimate both our liability under the contract and the appropriate rates to decrease the liability over the term of the contract. We report income from this contract, net of any losses, as other operating income in our consolidated statements of income. | ||
Acquisition and Goodwill | ||
On January 2, 2008, we acquired MultiNational Underwriters, LLC, an underwriting agency located in Indianapolis, Indiana, for $42.7 million in cash and a possible additional earnout depending upon future underwriting profit levels. This agency writes domestic and international short-term medical insurance. The results of operations of MultiNational Underwriters were included in our condensed consolidated financial statements beginning on the effective date of the transaction. We valued all identifiable assets and liabilities at fair value and allocated $39.4 million to goodwill in our purchase price allocation. When the conditions for the earnout have been satisfied under the purchase agreement, we will record a liability to the former owners with an offsetting increase to goodwill. The goodwill will be deductible for United States Federal income tax purposes. | ||
When we complete an acquisition, the related goodwill is allocated to our reporting units based on their respective share of estimated future cash flows from the acquired entity. We allocated $20.0 million and $19.4 million of the MultiNational Underwriters, LLC. goodwill to reporting units in our insurance company and agency segments, respectively. During the second quarter of 2008, we transferred $27.3 million of goodwill from our agency segment to our insurance company segment, based on a reorganization that shifted cash flows from a reporting unit in our agency segment to reporting units in our insurance company segment. |
9
Income Tax | ||
For the six months ended June 30, 2008 and 2007, the income tax provision was calculated based on an estimated effective tax rate for each fiscal year. Our effective tax rate differs from the United States Federal statutory rate primarily due to tax-exempt municipal bond interest and state income taxes. | ||
Stock-Based Compensation | ||
During the second quarter of 2008, we granted fully-vested common stock valued at $80,000 to each non-management director as part of their annual compensation for serving on our Board of Directors. The number of shares granted to each director was based on the closing price on the grant date, which was the day of our Annual Meeting of Shareholders. The 30,000 shares granted had an aggregate fair value of $0.7 million, which we recognized as compensation expense on the grant date. | ||
In the second quarter of 2008, we granted 46,000 shares of restricted stock at $23.43 per share. In the first quarter of 2008, we granted 10,000 shares at $22.02. The restricted stock requires continuous service during the vesting period of three to four years. The restricted stock granted had an aggregate fair value of $2.0 million, which will be expensed over the vesting period. | ||
In the second quarter of 2008, we granted 142,500 options for the purchase of shares of our common stock at $23.43 per share. In the first quarter of 2008, we granted options for the purchase of 180,000 shares at $22.02 per share. The options granted had an aggregate fair value of $1.2 million, which will be expensed over the vesting period of three to five years. | ||
Recent Accounting Pronouncements | ||
The Financial Accounting Standards Board (FASB) has issued FSP FAS 157-2, Effective Date of FASB Statement No. 157, to delay the effective date of SFAS No. 157, Fair Value Measurements, (discussed in Note 2 below) for nonfinancial assets and nonfinancial liabilities measured at fair value on a nonrecurring basis. For these items, FSP 157-2 will be effective January 1, 2009. We are evaluating what impact these future additional SFAS 157 requirements will have on our consolidated financial statements. | ||
SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities, issued by the FASB, became effective January 1, 2008. SFAS 159 allows a company to make an irrevocable election to measure eligible financial assets and financial liabilities at fair value that are not otherwise measured at fair value. Unrealized gains and losses for those items are reported in current earnings at each subsequent reporting date. As of January 1, 2008, we have not elected to value any additional assets or liabilities at fair value under the guidance of SFAS 159. | ||
The FASB has issued SFAS No. 141 (revised 2007) (SFAS 141(R)), Business Combinations, and SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of Accounting Research Bulletin No. 51. SFAS 141(R) will change the accounting treatment for business combinations and will impact presentation of financial statements on the acquisition date and accounting for acquisitions in subsequent periods. SFAS 160 will change the accounting and reporting for minority interests, which will be recharacterized as noncontrolling interests and classified as a component of shareholders equity. SFAS 141(R) and SFAS 160 will be effective January 1, 2009, and early adoption is not permitted. We are evaluating the impact SFAS 141(R) and SFAS 160 will have on our consolidated financial statements. | ||
The FASB has issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities - an amendment of FASB Statement No. 133, which expands the required disclosures about a companys derivative and hedging activities. SFAS 161 will be effective January 1, 2009. We are evaluating the impact SFAS 161 will have on the notes to our consolidated financial statements. |
10
The FASB has issued FSP APB 14-1, Accounting for Convertible Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement). APB 14-1 clarifies that convertible debt instruments that may be settled in cash upon conversion are not totally debt and requires issuers to bifurcate and separately account for the liability and equity components. The pronouncement, which is effective January 1, 2009, requires restatement of prior financial statements and does not permit early adoption. We must adopt APB 14-1 for our Convertible Notes, and we are assessing the impact adoption will have on our consolidated financial statements. | ||
The FASB has issued FSP EITF 03-6-1, Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities. EITF 03-6-1 clarifies whether instruments, such as restricted stock, granted in share-based payments are participating securities prior to vesting, which must be included in computing earnings per share under the two-class method described in SFAS No. 128, Earnings per Share. EITF 03-6-1 is effective January 1, 2009, requires restatement of prior financial statements and does not permit early adoption. We must adopt EITF 03-6-1 for our restricted stock, and we are assessing the impact adoption will have on our consolidated financial statements. | ||
(2) | FAIR VALUE MEASUREMENTS | |
Effective January 1, 2008, we adopted SFAS No. 157, Fair Value Measurements, for financial assets and financial liabilities measured at fair value on a recurring basis (at least annually). SFAS 157 defines fair value, establishes a consistent framework for measuring fair value and expands disclosure requirements about fair value measurements. Our adoption of SFAS 157 did not impact our 2008 or prior years consolidated financial position, results of operations or cash flows. | ||
SFAS 157 applies to all financial instruments that are measured and reported at fair value. SFAS 157 defines fair value as the price that would be received to sell an asset or would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, we generally apply the market approach, which uses prices and other relevant data based on market transactions involving identical or comparable assets and liabilities. The degree of judgment used to measure fair value generally correlates to the type of pricing and other data used as inputs, or assumptions, in the valuation process. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our own market assumptions using the best information available to us. Based on the type of inputs used to measure the fair value of our financial instruments, we classify them into the following three-level hierarchy established by SFAS 157: |
| Level 1 Inputs are based on quoted prices in active markets for identical instruments. | ||
| Level 2 Inputs are based on observable market data (other than quoted prices), or are derived from or corroborated by observable market data. | ||
| Level 3 Inputs are unobservable and not corroborated by market data. |
Our Level 1 instruments are primarily U.S. Treasuries and equity securities listed on stock exchanges. We use quoted prices for identical instruments to measure fair value. | ||
Our Level 2 instruments include most of our fixed income securities, which consist of U.S. government agency securities, municipal bonds, certain corporate debt securities, and certain mortgage and asset-backed securities. Our Level 2 instruments also include our interest rate swap agreements, which were reflected as liabilities in our consolidated balance sheet at June 30, 2008. We measure fair value for the majority of our Level 2 instruments using quoted prices of securities with similar characteristics. The remaining instruments are valued using pricing models or matrix pricing. The fair value measurements consider observable assumptions, including benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, default rates, loss severity and other economic measures. To validate quoted and modeled prices, we perform various procedures, including evaluation of the underlying methodologies, analysis of recent sales activity, if any, and analytical review of our fair values against current market prices and trends. |
11
Our Level 3 securities include certain fixed income securities, a former short-term investment with extended repayment terms and two insurance contracts that we account for as derivatives. Fair value is based on internally developed models that use our assumptions or other data that are not readily observable from objective sources. Because we use the lowest level significant input to determine our hierarchy classifications, a financial instrument may be classified in Level 3 even though there may be significant readily-observable inputs. | ||
We have excluded from our SFAS 157 disclosures certain assets, such as alternative investments and certain strategic investments in insurance-related companies, since we account for them using the equity method of accounting and have not elected to measure them at fair value, pursuant to the guidance of SFAS 159. These assets had a recorded value of approximately $164.7 million at June 30, 2008. |
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Fixed income securities |
$ | 89,718 | $ | 3,970,846 | $ | 7,459 | $ | 4,068,023 | ||||||||
Short-term investments |
204 | | | 204 | ||||||||||||
Other investments |
17,011 | | 1,847 | 18,858 | ||||||||||||
Other assets |
| | 19,582 | 19,582 | ||||||||||||
Total assets measured at fair value |
$ | 106,933 | $ | 3,970,846 | $ | 28,888 | $ | 4,106,667 | ||||||||
Accounts payable and accrued liabilities |
$ | | $ | 3,665 | $ | | $ | 3,665 | ||||||||
Total liabilities measured at fair value |
$ | | $ | 3,665 | $ | | $ | 3,665 | ||||||||
Fixed | ||||||||||||||||
income | Other | Other | ||||||||||||||
securities | investments | assets | Total | |||||||||||||
Balance at January 1, 2008 |
$ | 7,623 | $ | 5,492 | $ | 16,804 | $ | 29,919 | ||||||||
Net redemptions |
(239 | ) | (3,658 | ) | | (3,897 | ) | |||||||||
Other-than-temporary impairment loss realized |
(203 | ) | | | (203 | ) | ||||||||||
Gains and (losses) unrealized |
(262 | ) | 13 | 2,778 | 2,529 | |||||||||||
Net transfers in/out of Level 3 |
540 | | | 540 | ||||||||||||
Balance at June 30, 2008 |
$ | 7,459 | $ | 1,847 | $ | 19,582 | $ | 28,888 | ||||||||
12
Fixed | ||||||||||||||||
income | Other | Other | ||||||||||||||
securities | investments | assets | Total | |||||||||||||
Balance at April 1, 2008 |
$ | 6,948 | $ | 3,576 | $ | 18,136 | $ | 28,660 | ||||||||
Net redemptions |
| (1,783 | ) | | (1,783 | ) | ||||||||||
Other-than-temporary impairment loss realized |
(203 | ) | | | (203 | ) | ||||||||||
Gains and (losses) unrealized |
174 | 54 | 1,446 | 1,674 | ||||||||||||
Net transfers in/out of Level 3 |
540 | | | 540 | ||||||||||||
Balance at June 30, 2008 |
$ | 7,459 | $ | 1,847 | $ | 19,582 | $ | 28,888 | ||||||||
Unrealized gains and losses on our Level 3 fixed income securities and other investments are reported in other comprehensive income within shareholders equity, and unrealized gains and losses on our Level 3 other assets are reported in other operating income. | ||
(3) | REINSURANCE | |
In the normal course of business, our insurance companies cede a portion of their premium to domestic and foreign reinsurers through treaty and facultative reinsurance agreements. Although ceding for reinsurance purposes does not discharge the primary insurer from liability to its policyholder, our insurance companies participate in such agreements in order to limit their loss exposure, protect them against catastrophic loss and diversify their business. The following table presents the effect of such reinsurance transactions on our premium and loss and loss adjustment expense. |
Loss and loss | ||||||||||||
Written | Earned | adjustment | ||||||||||
premium | premium | expense | ||||||||||
Six months ended June 30, 2008 |
||||||||||||
Direct business |
$ | 1,055,842 | $ | 1,028,684 | $ | 606,097 | ||||||
Reinsurance assumed |
218,750 | 196,243 | 186,290 | |||||||||
Reinsurance ceded |
(213,795 | ) | (224,771 | ) | (196,460 | ) | ||||||
Net amounts |
$ | 1,060,797 | $ | 1,000,156 | $ | 595,927 | ||||||
Six months ended June 30, 2007 |
||||||||||||
Direct business |
$ | 1,011,630 | $ | 978,161 | $ | 570,661 | ||||||
Reinsurance assumed |
253,072 | 227,101 | 152,399 | |||||||||
Reinsurance ceded |
(233,917 | ) | (213,276 | ) | (119,297 | ) | ||||||
Net amounts |
$ | 1,030,785 | $ | 991,986 | $ | 603,763 | ||||||
13
Loss and loss | ||||||||||||
Written | Earned | adjustment | ||||||||||
premium | premium | expense | ||||||||||
Three months ended June 30, 2008 |
||||||||||||
Direct business |
$ | 572,696 | $ | 517,061 | $ | 313,286 | ||||||
Reinsurance assumed |
118,897 | 103,173 | 117,018 | |||||||||
Reinsurance ceded |
(124,443 | ) | (113,624 | ) | (127,403 | ) | ||||||
Net amounts |
$ | 567,150 | $ | 506,610 | $ | 302,901 | ||||||
Three months ended June 30, 2007 |
||||||||||||
Direct business |
$ | 553,128 | $ | 492,791 | $ | 283,210 | ||||||
Reinsurance assumed |
112,473 | 110,628 | 89,402 | |||||||||
Reinsurance ceded |
(131,781 | ) | (109,033 | ) | (69,321 | ) | ||||||
Net amounts |
$ | 533,820 | $ | 494,386 | $ | 303,291 | ||||||
Ceding commissions netted with policy acquisition costs in the condensed consolidated statements of earnings were $25.1 million in the first six months of 2008 and $21.8 million in the first six months of 2007. | ||
The table below shows the components of reinsurance recoverables in our condensed consolidated balance sheets. |
June 30, | December 31, | |||||||
2008 | 2007 | |||||||
Reinsurance recoverable on paid losses |
$ | 68,280 | $ | 80,915 | ||||
Reinsurance recoverable on outstanding losses |
520,663 | 458,190 | ||||||
Reinsurance recoverable on incurred but not reported losses |
449,910 | 426,090 | ||||||
Reserve for uncollectible reinsurance |
(8,445 | ) | (8,530 | ) | ||||
Total reinsurance recoverables |
$ | 1,030,408 | $ | 956,665 | ||||
Our reserve for uncollectible reinsurance covers potential collectibility issues, including disputed amounts and associated expenses. While we believe the reserve is adequate based on information currently available, market conditions may change or additional information might be obtained that may require us to change the reserve in the future. | ||
We limit the liquidity exposure related to our reinsurance recoverables by holding funds, letters of credit or other security, with the result that net balances due are significantly less than the gross balances shown in our condensed consolidated balance sheets. Our U.S. domiciled insurance companies require reinsurers not authorized by the respective states of domicile of our insurance companies to collateralize their reinsurance obligations due to us. The table below shows the amounts of letters of credit and cash deposits held by us as collateral, plus other credits available for potential offset. |
June 30, | December 31, | |||||||
2008 | 2007 | |||||||
Payables to reinsurers |
$ | 260,776 | $ | 246,745 | ||||
Letters of credit |
181,304 | 188,400 | ||||||
Cash deposits |
109,048 | 114,549 | ||||||
Total credits |
$ | 551,128 | $ | 549,694 | ||||
14
The tables below present the calculation of net reserves, net unearned premium and net deferred policy acquisition costs. |
June 30, | December 31, | |||||||
2008 | 2007 | |||||||
Loss and loss adjustment expense payable |
$ | 3,446,824 | $ | 3,227,080 | ||||
Reinsurance recoverable on outstanding losses |
(520,663 | ) | (458,190 | ) | ||||
Reinsurance recoverable on incurred but not reported losses |
(449,910 | ) | (426,090 | ) | ||||
Net reserves |
$ | 2,476,251 | $ | 2,342,800 | ||||
Unearned premium |
$ | 998,922 | $ | 943,946 | ||||
Ceded unearned premium |
(235,632 | ) | (244,684 | ) | ||||
Net unearned premium |
$ | 763,290 | $ | 699,262 | ||||
Deferred policy acquisition costs |
$ | 200,576 | $ | 192,773 | ||||
Deferred ceding commissions |
(60,891 | ) | (68,968 | ) | ||||
Net deferred policy acquisition costs |
$ | 139,685 | $ | 123,805 | ||||
(4) | EARNINGS PER SHARE | |
The following table details the numerator and denominator used in the earnings per share calculations. |
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Net earnings |
$ | 173,438 | $ | 197,862 | $ | 92,337 | $ | 101,172 | ||||||||
Weighted average common shares outstanding |
115,363 | 112,117 | 115,492 | 112,273 | ||||||||||||
Dilutive effect of restricted stock and
outstanding options (determined using
treasury stock method) |
445 | 1,045 | 375 | 1,069 | ||||||||||||
Dilutive effect of convertible debt
(determined using treasury stock method) |
410 | 4,219 | 208 | 4,386 | ||||||||||||
Weighted average common shares and
potential common shares outstanding |
116,218 | 117,381 | 116,075 | 117,728 | ||||||||||||
Anti-dilutive stock options not included
in treasury stock method computation |
5,851 | 2,482 | 6,152 | 3,268 | ||||||||||||
15
(5) | SEGMENT AND GEOGRAPHIC INFORMATION | |
Our management evaluates the performance of each segment based on net earnings. Net earnings is calculated after tax and after allocation of certain corporate expenses and certain intercompany interest. All stock-based compensation expense, unallocated corporate expenses and unallocated interest expense are included in the corporate segment since these costs are not included in managements evaluation of the other segments. The following tables show information by business segment and geographic location. Geographic location is determined by physical location of our offices and does not represent the location of insureds or reinsureds from whom the business was generated. |
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Six months ended June 30, 2008 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 925,070 | $ | 26,274 | $ | 3,709 | $ | 453 | $ | 955,506 | ||||||||||
Foreign |
186,417 | 19,315 | | | 205,732 | |||||||||||||||
Inter-segment |
| 39,785 | | | 39,785 | |||||||||||||||
Total segment revenue |
$ | 1,111,487 | $ | 85,374 | $ | 3,709 | $ | 453 | 1,201,023 | |||||||||||
Inter-segment eliminations |
(39,785 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 1,161,238 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 127,785 | $ | 9,938 | $ | 949 | $ | (11,773 | ) | $ | 126,899 | |||||||||
Foreign |
46,529 | 226 | | | 46,755 | |||||||||||||||
Total segment net earnings (loss) |
$ | 174,314 | $ | 10,164 | $ | 949 | $ | (11,773 | ) | 173,654 | ||||||||||
Inter-segment eliminations |
(216 | ) | ||||||||||||||||||
Consolidated net earnings |
$ | 173,438 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 91,699 | $ | 2,758 | $ | 31 | $ | 382 | $ | 94,870 | ||||||||||
Depreciation and amortization |
2,367 | 2,996 | 65 | 1,396 | 6,824 | |||||||||||||||
Interest expense (benefit) |
404 | 7,729 | (51 | ) | (315 | ) | 7,767 | |||||||||||||
Capital expenditures |
1,789 | 2,371 | 69 | 1,446 | 5,675 | |||||||||||||||
Income tax expense (benefit) |
$ | 76,585 | $ | 7,988 | $ | (492 | ) | $ | (4,649 | ) | $ | 79,432 | ||||||||
Inter-segment eliminations |
(157 | ) | ||||||||||||||||||
Consolidated income tax expense |
$ | 79,275 | ||||||||||||||||||
16
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Six months ended June 30, 2007 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 916,844 | $ | 29,999 | $ | 38,226 | $ | 997 | $ | 986,066 | ||||||||||
Foreign |
186,850 | 18,556 | | | 205,406 | |||||||||||||||
Inter-segment |
| 37,650 | | | 37,650 | |||||||||||||||
Total segment revenue |
$ | 1,103,694 | $ | 86,205 | $ | 38,226 | $ | 997 | 1,229,122 | |||||||||||
Inter-segment eliminations |
(37,650 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 1,191,472 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 132,349 | $ | 12,162 | $ | 24,177 | $ | (9,566 | ) | $ | 159,122 | |||||||||
Foreign |
36,037 | 2,108 | | | 38,145 | |||||||||||||||
Total segment net earnings (loss) |
$ | 168,386 | $ | 14,270 | $ | 24,177 | $ | (9,566 | ) | 197,267 | ||||||||||
Inter-segment eliminations |
595 | |||||||||||||||||||
Consolidated net earnings |
$ | 197,862 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 90,794 | $ | 4,721 | $ | 2,010 | $ | 639 | $ | 98,164 | ||||||||||
Depreciation and amortization |
2,353 | 3,945 | 148 | 1,415 | 7,861 | |||||||||||||||
Interest expense (benefit) |
836 | 5,894 | 5 | (2,336 | ) | 4,399 | ||||||||||||||
Capital expenditures |
2,457 | 987 | 316 | 1,596 | 5,356 | |||||||||||||||
Income tax expense (benefit) |
$ | 79,965 | $ | 12,110 | $ | 12,824 | $ | (5,733 | ) | $ | 99,166 | |||||||||
Inter-segment eliminations |
647 | |||||||||||||||||||
Consolidated income tax expense |
$ | 99,813 | ||||||||||||||||||
17
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Three months ended June 30, 2008 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 468,142 | $ | 12,323 | $ | 9,954 | $ | 121 | $ | 490,540 | ||||||||||
Foreign |
93,720 | 9,590 | | - | 103,310 | |||||||||||||||
Inter-segment |
| 22,676 | | - | 22,676 | |||||||||||||||
Total segment revenue |
$ | 561,862 | $ | 44,589 | $ | 9,954 | $ | 121 | 616,526 | |||||||||||
Inter-segment eliminations |
(22,676 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 593,850 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 61,055 | $ | 5,253 | $ | 6,029 | $ | (4,106 | ) | $ | 68,231 | |||||||||
Foreign |
25,673 | (195 | ) | | - | 25,478 | ||||||||||||||
Total segment net earnings (loss) |
$ | 86,728 | $ | 5,058 | $ | 6,029 | $ | (4,106 | ) | 93,709 | ||||||||||
Inter-segment eliminations |
(1,372 | ) | ||||||||||||||||||
Consolidated net earnings |
$ | 92,337 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 45,943 | $ | 1,205 | $ | 14 | $ | 87 | $ | 47,249 | ||||||||||
Depreciation and amortization |
1,186 | 1,505 | 30 | 713 | 3,434 | |||||||||||||||
Interest expense (benefit) |
273 | 5,223 | (25 | ) | (1,663 | ) | 3,808 | |||||||||||||
Capital expenditures |
1,138 | 1,143 | 67 | 667 | 3,015 | |||||||||||||||
Income tax expense (benefit) |
$ | 38,015 | $ | 4,443 | $ | 3,219 | $ | (3,369 | ) | $ | 42,308 | |||||||||
Inter-segment eliminations |
(863 | ) | ||||||||||||||||||
Consolidated income tax expense |
$ | 41,445 | ||||||||||||||||||
18
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Three months ended June 30, 2007 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 458,084 | $ | 15,042 | $ | 19,950 | $ | 600 | $ | 493,676 | ||||||||||
Foreign |
92,041 | 8,533 | | | 100,574 | |||||||||||||||
Inter-segment |
| 23,664 | | | 23,664 | |||||||||||||||
Total segment revenue |
$ | 550,125 | $ | 47,239 | $ | 19,950 | $ | 600 | 617,914 | |||||||||||
Inter-segment eliminations |
(23,664 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 594,250 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 65,554 | $ | 7,458 | $ | 12,798 | $ | (3,481 | ) | $ | 82,329 | |||||||||
Foreign |
18,656 | 1,887 | | | 20,543 | |||||||||||||||
Total segment net earnings (loss) |
$ | 84,210 | $ | 9,345 | $ | 12,798 | $ | (3,481 | ) | 102,872 | ||||||||||
Inter-segment eliminations |
(1,700 | ) | ||||||||||||||||||
Consolidated net earnings |
$ | 101,172 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 45,029 | $ | 2,283 | $ | 1,023 | $ | 362 | $ | 48,697 | ||||||||||
Depreciation and amortization |
1,174 | 2,199 | 36 | 716 | 4,125 | |||||||||||||||
Interest expense (benefit) |
372 | 3,129 | (25 | ) | (2,380 | ) | 1,096 | |||||||||||||
Capital expenditures |
1,429 | 333 | 316 | 1,110 | 3,188 | |||||||||||||||
Income tax expense (benefit) |
$ | 39,884 | $ | 7,638 | $ | 6,334 | $ | (3,196 | ) | $ | 50,660 | |||||||||
Inter-segment eliminations |
(864 | ) | ||||||||||||||||||
Consolidated income tax expense |
$ | 49,796 | ||||||||||||||||||
19
The following tables present selected revenue items by line of business. |
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Diversified financial products |
$ | 390,083 | $ | 385,851 | $ | 197,906 | $ | 193,337 | ||||||||
Group life, accident and health |
387,800 | 384,640 | 195,354 | 192,224 | ||||||||||||
Aviation |
69,712 | 77,091 | 34,719 | 37,747 | ||||||||||||
London market account |
53,395 | 64,499 | 26,305 | 30,603 | ||||||||||||
Other specialty lines |
94,426 | 80,335 | 47,580 | 40,597 | ||||||||||||
Discontinued lines |
4,740 | (430 | ) | 4,746 | (122 | ) | ||||||||||
Net earned premium |
$ | 1,000,156 | $ | 991,986 | $ | 506,610 | $ | 494,386 | ||||||||
Property and casualty |
$ | 50,722 | $ | 53,960 | $ | 25,468 | $ | 26,485 | ||||||||
Accident and health |
11,041 | 9,301 | 5,296 | 4,651 | ||||||||||||
Fee and commission income |
$ | 61,763 | $ | 63,261 | $ | 30,764 | $ | 31,136 | ||||||||
(6) SUPPLEMENTAL INFORMATION |
||||||||||||||||
Supplemental cash flow information was as follows. |
||||||||||||||||
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Cash received from commutations |
$ | 7,500 | $ | 101,040 | $ | | $ | | ||||||||
Income taxes paid |
89,796 | 82,492 | 73,685 | 72,107 | ||||||||||||
Interest paid |
7,136 | 3,596 | 3,045 | 278 | ||||||||||||
Comprehensive income |
135,375 | 152,020 | 48,322 | 60,722 |
(7) | COMMITMENTS AND CONTINGENCIES | |
Litigation | ||
Based on a voluntary independent investigation by a Special Committee of the Board of Directors in 2006 of our past practices related to granting stock options, we determined that the price on the actual measurement date for a number of our stock option grants from 1997 through 2005 and into 2006 did not correspond to the price on the stated grant date and that certain option grants were retroactively priced. The investigation was conducted with the help of a law firm that was not previously involved with our stock option plans and procedures. The Special Committee completed the investigation on November 16, 2006. Based upon the Special Committees recommendations, the Board of Directors took specific actions. The SEC commenced an informal inquiry upon notification by us of the initiation of our investigation. We provided the results of our internal review and independent investigation to the SEC, and we responded to requests from the SEC for documents and additional information. In March 2007, the SEC issued a formal order directing a private investigation. We fully cooperated with the investigation. In July 2008, the Company reached a settlement with the SEC by consenting to the entry of a permanent injunction against future violations of the reporting, books and records, and internal controls provisions of the federal securities laws. The Company neither admitted nor denied the allegations contained in the SECs complaint. The SEC did not allege fraud claims and did not seek a monetary penalty against the Company based in part on our remedial measures and extraordinary cooperation in the SECs investigation. |
20
We are a party to lawsuits, arbitrations and other proceedings that arise in the normal course of our business. Many of such lawsuits, arbitrations and other proceedings involve claims under policies that we underwrite as an insurer or reinsurer, the liabilities for which, we believe, have been adequately included in our loss reserves. Also, from time to time, we are a party to lawsuits, arbitrations and other proceedings that relate to disputes over contractual relationships with third parties, or that involve alleged errors and omissions on the part of our subsidiaries. We have provided accruals for these items to the extent we deem the losses probable and reasonably estimable. Although the ultimate outcome of the above matters cannot be determined at this time, based on present information, the availability of insurance coverage and advice received from our outside legal counsel, we believe the resolution of any such matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. | ||
In addition to the litigation discussed above, the following lawsuit, relating to the outcome of our stock option investigation, was settled in the second quarter of 2008: | ||
Civil Action No. 07-0801; In re HCC Insurance Holdings, Inc. Securities Litigation; In the United States District Court for the Southern District of Texas, Houston Division (formerly referred to as Bristol County Retirement System, individually and on behalf of all others similarly situated v. HCC Insurance Holdings, Inc. et al.). This action was filed on March 8, 2007. We were named as a defendant in this putative class action along with certain current and former officers and directors. On February 7, 2008, the parties reached an agreement to settle the case and proposed the settlement to the Court for approval. The terms of the settlement, which included no admission of liability or wrongdoing by the Company or any other defendants, provided for a full and complete release of all claims in the litigation and payment of $10.0 million into a settlement fund. At a hearing on April 17, 2008, the Court gave preliminary approval of the proposed settlement. At a hearing on July 17, 2008, the Court gave final approval for the settlement and entered final judgment, concluding the matter. The $10.0 million was paid by our directors and officers liability insurers. | ||
Indemnifications | ||
In conjunction with the sales of certain business assets and subsidiaries, we have provided indemnifications to the purchasers. Certain indemnifications cover typical representations and warranties related to our responsibilities to perform under the sales contracts. Other indemnifications agree to reimburse the purchasers for taxes or ERISA-related amounts, if any, assessed after the sale date but related to pre-sale activities. We cannot quantify the maximum potential exposure covered by all of our indemnifications because the indemnifications cover a variety of matters, operations and scenarios. Certain of these indemnifications have no time limit. For those with a time limit, the longest indemnification expires on December 31, 2009. We accrue a loss when a valid claim is made by a purchaser and we believe we have potential exposure. At June 30, 2008, we have recorded a liability of $16.5 million and have provided $5.2 million of letters of credit to cover our obligations or anticipated payments under these indemnifications. | ||
Pursuant to our by-laws, Delaware Corporate law and certain contractual agreements, we are required to advance attorneys fees and other expenses and may be required to indemnify our current and former directors and officers for liabilities arising from any action, suit or proceeding brought because the individual was acting as an officer or director of the Company. Under certain limited circumstances, the individual may be required to reimburse us for any advances or indemnification payments made by us. In addition, we maintain directors and officers liability insurance, which may cover certain of these costs. We expense payments as advanced and recognize offsets if cash reimbursement is expected or received. It is not possible to determine the maximum potential impact on our future consolidated net earnings of any such indemnification costs, since our by-laws, Delaware law and our contractual agreements do not limit any such advances or indemnification payments. |
21
| risk-bearing earned premium produced by our insurance company operations, | ||
| non-risk-bearing fee and commission income received by our underwriting agency and broker operations, | ||
| ceding commissions in excess of policy acquisition costs earned by our insurance company operations, | ||
| investment income earned by all of our operations, and | ||
| other operating income. |
Effective date | ||||
Company | Segment | acquired | ||
Promoregistration.com
|
Agency | March 2, 2007 | ||
Pioneer General Insurance Company
|
Insurance Company | November 1, 2007 | ||
MultiNational Underwriters, LLC
|
Agency | January 2, 2008 |
22
| Our trading portfolio had losses of $11.7 million in 2008, compared to gains of $8.3 million in 2007. There were losses of $2.7 million in the second quarter of 2008, compared to gains of $6.1 million in the second quarter of 2007. These gains and losses are reported in other operating income. We discontinued the active trading of securities in late 2006 and sold the majority of the remaining two stocks in the second quarter of 2008. | ||
| We sold strategic investments in 2008 and 2007 and realized gains of $9.2 million and $21.6 million, respectively. The second quarter gains were $9.2 million in 2008 and $10.8 million in 2007. These gains are reported in other operating income. | ||
| Our alternative investments generated $2.4 million of losses in 2008, compared to $12.6 million of income in 2007. These investments generated $1.2 million of losses in the second quarter of 2008, compared to $5.0 million of income in the second quarter of 2007. The related income or loss is included in net investment income. | ||
| We recognized other-than-temporary impairments of $1.6 million in our available for sale securities portfolio in the second quarter of 2008, which we recorded in net realized investment loss. There were no such impairments recorded in 2007. |
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Net earned premium |
86.1 | % | 83.3 | % | 85.3 | % | 83.2 | % | ||||||||
Fee and commission income |
5.3 | 5.3 | 5.2 | 5.2 | ||||||||||||
Net investment income |
8.2 | 8.2 | 8.0 | 8.2 | ||||||||||||
Net realized investment loss |
(0.1 | ) | (0.1 | ) | (0.3 | ) | | |||||||||
Other operating income |
0.5 | 3.3 | 1.8 | 3.4 | ||||||||||||
Total revenue |
100.0 | 100.0 | 100.0 | 100.0 | ||||||||||||
Loss and loss adjustment expense, net |
51.3 | 50.7 | 51.0 | 51.0 | ||||||||||||
Policy acquisition costs, net |
16.2 | 14.6 | 16.1 | 14.4 | ||||||||||||
Other operating expense |
10.1 | 9.3 | 9.7 | 9.0 | ||||||||||||
Interest expense |
0.7 | 0.4 | 0.6 | 0.2 | ||||||||||||
Earnings before income tax expense |
21.7 | 25.0 | 22.6 | 25.4 | ||||||||||||
Income tax expense |
6.8 | 8.4 | 7.0 | 8.4 | ||||||||||||
Net earnings |
14.9 | % | 16.6 | % | 15.6 | % | 17.0 | % | ||||||||
23
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Gross written premium |
$ | 1,274,592 | $ | 1,264,702 | $ | 691,593 | $ | 665,601 | ||||||||
Net written premium |
1,060,797 | 1,030,785 | 567,150 | 533,820 | ||||||||||||
Net earned premium |
1,000,156 | 991,986 | 506,610 | 494,386 | ||||||||||||
Fee and commission income declined slightly in 2008. The table below shows the source of our fee
and commission income. |
||||||||||||||||
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Agency |
$ | 43,818 | $ | 45,133 | $ | 21,534 | $ | 21,777 | ||||||||
Insurance companies |
17,945 | 18,128 | 9,230 | 9,359 | ||||||||||||
Fee and commission income |
$ | 61,763 | $ | 63,261 | $ | 30,764 | $ | 31,136 | ||||||||
The sources of net investment income are detailed below.
|
||||||||||||||||
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Fixed income securities |
||||||||||||||||
Taxable |
$ | 47,322 | $ | 41,488 | $ | 24,870 | $ | 21,476 | ||||||||
Exempt from U.S. income taxes |
37,974 | 28,908 | 19,502 | 14,913 | ||||||||||||
Total fixed income securities |
85,296 | 70,396 | 44,372 | 36,389 | ||||||||||||
Short-term investments |
13,571 | 18,022 | 4,979 | 8,349 | ||||||||||||
Alternative investments |
(2,414 | ) | 12,569 | (1,209 | ) | 5,049 | ||||||||||
Other investments |
498 | | 231 | | ||||||||||||
Total investment income |
96,951 | 100,987 | 48,373 | 49,787 | ||||||||||||
Investment expense |
(2,081 | ) | (2,823 | ) | (1,124 | ) | (1,090 | ) | ||||||||
Net investment income |
$ | 94,870 | $ | 98,164 | $ | 47,249 | $ | 48,697 | ||||||||
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Average fixed income yield* |
4.4 | % | 4.5 | % | 4.4 | % | 4.3 | % | ||||||||
Average fixed income tax equivalent yield* |
5.3 | % | 5.3 | % | 5.3 | % | 5.1 | % | ||||||||
Weighted average maturity |
7.0 years | 7.0 years | ||||||||||||||
Weighted average duration |
5.0 years | 4.9 years | ||||||||||||||
Average rating on fixed income securities |
AA+ | AAA |
* | Excluding realized and unrealized gains and losses. |
24
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Strategic investments |
$ | 12,164 | $ | 23,237 | $ | 11,251 | $ | 11,578 | ||||||||
Trading securities |
(11,727 | ) | 8,274 | (2,699 | ) | 6,093 | ||||||||||
Financial instruments |
2,782 | 2,693 | 1,446 | 1,506 | ||||||||||||
Contract using deposit accounting |
302 | | 302 | | ||||||||||||
Other |
2,480 | 4,481 | 647 | 923 | ||||||||||||
Other operating income |
$ | 6,001 | $ | 38,685 | $ | 10,947 | $ | 20,100 | ||||||||
25
Gross | Net | NWP | Net | |||||||||||||
written | written | as % of | earned | |||||||||||||
premium | premium | GWP | premium | |||||||||||||
Six months ended June 30, 2008 |
||||||||||||||||
Diversified financial products |
$ | 483,306 | $ | 407,146 | 84 | % | $ | 390,083 | ||||||||
Group life, accident and health |
418,284 | 399,829 | 96 | 387,800 | ||||||||||||
Aviation |
96,629 | 69,880 | 72 | 69,712 | ||||||||||||
London market account |
122,798 | 80,096 | 65 | 53,395 | ||||||||||||
Other specialty lines |
148,936 | 99,161 | 67 | 94,426 | ||||||||||||
Discontinued lines |
4,639 | 4,685 | nm | 4,740 | ||||||||||||
Totals |
$ | 1,274,592 | $ | 1,060,797 | 83 | % | $ | 1,000,156 | ||||||||
Six months ended June 30, 2007 |
||||||||||||||||
Diversified financial products |
$ | 472,402 | $ | 379,715 | 80 | % | $ | 385,851 | ||||||||
Group life, accident and health |
405,174 | 383,948 | 95 | 384,640 | ||||||||||||
Aviation |
106,093 | 77,843 | 73 | 77,091 | ||||||||||||
London market account |
149,222 | 93,969 | 63 | 64,499 | ||||||||||||
Other specialty lines |
132,276 | 95,741 | 72 | 80,335 | ||||||||||||
Discontinued lines |
(465 | ) | (431 | ) | nm | (430 | ) | |||||||||
Totals |
$ | 1,264,702 | $ | 1,030,785 | 82 | % | $ | 991,986 | ||||||||
Three months ended June 30, 2008 |
||||||||||||||||
Diversified financial products |
$ | 271,942 | $ | 226,645 | 83 | % | $ | 197,906 | ||||||||
Group life, accident and health |
207,750 | 197,454 | 95 | 195,354 | ||||||||||||
Aviation |
51,801 | 37,534 | 72 | 34,719 | ||||||||||||
London market account |
81,862 | 51,068 | 62 | 26,305 | ||||||||||||
Other specialty lines |
73,593 | 49,758 | 68 | 47,580 | ||||||||||||
Discontinued lines |
4,645 | 4,691 | nm | 4,746 | ||||||||||||
Totals |
$ | 691,593 | $ | 567,150 | 82 | % | $ | 506,610 | ||||||||
Three months ended June 30, 2007 |
||||||||||||||||
Diversified financial products |
$ | 260,149 | $ | 207,923 | 80 | % | $ | 193,337 | ||||||||
Group life, accident and health |
202,268 | 191,522 | 95 | 192,224 | ||||||||||||
Aviation |
54,430 | 38,240 | 70 | 37,747 | ||||||||||||
London market account |
81,087 | 48,837 | 60 | 30,603 | ||||||||||||
Other specialty lines |
67,781 | 47,420 | 70 | 40,597 | ||||||||||||
Discontinued lines |
(114 | ) | (122 | ) | nm | (122 | ) | |||||||||
Totals |
$ | 665,601 | $ | 533,820 | 80 | % | $ | 494,386 | ||||||||
nm Not meaningful comparison |
26
| Diversified financial products Premium increased from growth in our credit business. Increased quota share retentions on our U.S. professional indemnity and employment practices liability businesses in 2008 added to net written premium and the retention rate. Premium volume in our other major products was stable, although pricing for these products is down slightly. | ||
| Group life, accident and health The increase in premium is from our acquisition of MultiNational Underwriters in 2008, for which we use one of our managed Lloyds syndicates as the issuing carrier. The profit margin on our medical stop-loss business remains at an acceptable level despite competition, principally from the fully insured market. | ||
| Aviation Our aviation premium volume is down due to competition. Margins on the decreased premium volume are lower, but still acceptable. | ||
| London market account Gross premium levels are lower in the first half of 2008, but flat quarter-over-quarter. In 2008, we discontinued writing our marine excess of loss book of business, which was predominantly written in the first quarter of each year, due to unacceptable competitive rates. In addition, we have written other business in 2008 at lower, but still profitable, rates. The net impact of these changes was moderated by reduced reinsurance spending. Rates have softened due to benign catastrophe activity in the past two years, which has resulted in low London market loss ratios for catastrophe exposed business. | ||
| Other specialty lines We experienced growth in our other specialty lines of business from an increase in our Lloyds syndicate participation and increased writings of several products. Markets for these products are competitive and rates are down slightly. The decrease in average retention is due to the change in mix of business in this line. Future gross and net written premium will be reduced as an assumed quota share contract has ended. |
27
Six months ended June 30, | Three months ended June 30, | |||||||||||||||||||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||||||||||||||||||
Net | Net | Net | Net | Net | Net | Net | Net | |||||||||||||||||||||||||
earned | loss | earned | loss | earned | loss | earned | loss | |||||||||||||||||||||||||
premium | ratio | premium | ratio | premium | ratio | premium | ratio | |||||||||||||||||||||||||
Diversified
financial products |
$ | 390,083 | 45.8 | % | $ | 385,851 | 43.0 | % | $ | 197,906 | 45.4 | % | $ | 193,337 | 40.4 | % | ||||||||||||||||
Group life, accident
and health |
387,800 | 74.2 | 384,640 | 76.9 | 195,354 | 73.9 | 192,224 | 78.3 | ||||||||||||||||||||||||
Aviation |
69,712 | 62.2 | 77,091 | 54.5 | 34,719 | 66.9 | 37,747 | 59.1 | ||||||||||||||||||||||||
London market account |
53,395 | 35.5 | 64,499 | 63.7 | 26,305 | 37.8 | 30,603 | 70.8 | ||||||||||||||||||||||||
Other specialty lines |
94,426 | 67.7 | 80,335 | 69.4 | 47,580 | 68.5 | 40,597 | 69.0 | ||||||||||||||||||||||||
Discontinued lines |
4,740 | nm | (430 | ) | nm | 4,746 | nm | (122 | ) | nm | ||||||||||||||||||||||
Totals |
$ | 1,000,156 | 59.6 | % | $ | 991,986 | 60.9 | % | $ | 506,610 | 59.8 | % | $ | 494,386 | 61.3 | % | ||||||||||||||||
Expense Ratio |
24.3 | 23.1 | 24.3 | 22.6 | ||||||||||||||||||||||||||||
Combined Ratio |
83.9 | % | 84.0 | % | 84.1 | % | 83.9 | % | ||||||||||||||||||||||||
nm Not meaningful comparison |
| Diversified financial products The 2007 periods had more redundant development than comparable 2008 periods. The growth in our surety business, which has a lower loss ratio than other businesses in this line, mitigated the increase in the 2008 loss ratios. | ||
| Group life, accident and health The net loss ratio was higher in 2007 on the business acquired in the Health Products Division acquisition in late 2006. As the business has been re-underwritten, the loss ratio has declined. The 2007 periods also included some negative development from prior year losses. | ||
| Aviation The second quarter of 2008 had higher losses. | ||
| London market account During 2008, the net loss ratio benefited from redundant development, compared to adverse development in 2007. |
28
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Net reserves for loss and loss adjustment expense
payable at beginning of period |
$ | 2,342,800 | $ | 2,108,961 | $ | 2,429,355 | $ | 2,136,517 | ||||||||
Assumed book of business Lloyds syndicate |
29,053 | | | | ||||||||||||
Incurred loss and loss adjustment expense: |
||||||||||||||||
Current accident year |
610,325 | 600,129 | 312,172 | 299,904 | ||||||||||||
All prior accident years |
(14,398 | ) | 3,634 | (9,271 | ) | 3,387 | ||||||||||
Incurred loss and loss adjustment expense |
595,927 | 603,763 | 302,901 | 303,291 | ||||||||||||
Loss and loss adjustment expense payments |
(491,529 | ) | (485,908 | ) | (256,005 | ) | (212,992 | ) | ||||||||
Net reserves for loss and loss adjustment
expense
payable at end of period |
$ | 2,476,251 | $ | 2,226,816 | $ | 2,476,251 | $ | 2,226,816 | ||||||||
Net paid loss ratio |
49.1 | % | 49.0 | % | 50.5 | % | 43.1 | % | ||||||||
29
| our increasing net earnings, | ||
| growth in net written premium and net loss reserves due to organic growth, acquisitions and increased retentions, | ||
| commutations of selected reinsurance agreements, and | ||
| expansion of our diversified financial products line of business as a result of which we retain premium for a longer duration than had been the case prior to entering this business. |
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Net earnings |
$ | 173,438 | $ | 197,862 | $ | 92,337 | $ | 101,172 | ||||||||
Change in premium, claims and other
receivables, net of reinsurance, other
payables and restricted cash |
(127,437 | ) | (12,932 | ) | (80,006 | ) | (5,086 | ) | ||||||||
Change in unearned premium, net |
64,074 | 41,633 | 61,135 | 42,365 | ||||||||||||
Change in loss and loss adjustment
expense payable, net of reinsurance
recoverables |
146,046 | 200,558 | 51,530 | 72,846 | ||||||||||||
Change in trading portfolio |
42,574 | 4,865 | 33,512 | (6,093 | ) | |||||||||||
Other, net |
(68,256 | ) | (31,686 | ) | (63,869 | ) | (35,215 | ) | ||||||||
Cash provided by operating activities |
$ | 230,439 | $ | 400,300 | $ | 94,639 | $ | 169,989 | ||||||||
30
| Level 1 Inputs are based on quoted prices in active markets for identical instruments. | ||
| Level 2 Inputs are based on observable market data (other than quoted prices), or are derived from or corroborated by observable market data. | ||
| Level 3 Inputs are unobservable and not corroborated by market data. |
31
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Fixed income securities |
$ | 89,718 | $ | 3,970,846 | $ | 7,459 | $ | 4,068,023 | ||||||||
Short-term investments |
204 | | | 204 | ||||||||||||
Other investments |
17,011 | | 1,847 | 18,858 | ||||||||||||
Other assets |
| | 19,582 | 19,582 | ||||||||||||
Total assets measured at fair value |
$ | 106,933 | $ | 3,970,846 | $ | 28,888 | $ | 4,106,667 | ||||||||
Accounts payable and accrued liabilities |
$ | | $ | 3,665 | $ | | $ | 3,665 | ||||||||
Total liabilities measured at fair value |
$ | | $ | 3,665 | $ | | $ | 3,665 | ||||||||
Fixed | ||||||||||||||||
income | Other | Other | ||||||||||||||
securities | investments | assets | Total | |||||||||||||
Balance at January 1, 2008 |
$ | 7,623 | $ | 5,492 | $ | 16,804 | $ | 29,919 | ||||||||
Net redemptions |
(239 | ) | (3,658 | ) | | (3,897 | ) | |||||||||
Other-than-temporary impairment loss realized |
(203 | ) | | | (203 | ) | ||||||||||
Gains and (losses) unrealized |
(262 | ) | 13 | 2,778 | 2,529 | |||||||||||
Net transfers in/out of Level 3 |
540 | | | 540 | ||||||||||||
Balance at June 30, 2008 |
$ | 7,459 | $ | 1,847 | $ | 19,582 | $ | 28,888 | ||||||||
32
33
34
Approximate Dollar | ||||||||||||||||
Total Number of Shares | Value of Shares that | |||||||||||||||
Purchased as Part of | May Yet Be Purchased | |||||||||||||||
Total Number of | Average Price | Publicly Announced | Under the Plans or | |||||||||||||
Period | Shares Purchased | Paid Per Share | Plans or Programs | Programs | ||||||||||||
June 1 June 30, 2008 |
120,000 | $ | 21.52 | 120,000 | $ | 97,417,000 |
a. | Election of Directors | |
The following persons were elected to serve on the Board of Directors until the 2009 Annual Meeting of Shareholders or until their successors have been duly elected and qualified. The Directors received the votes next to their respective names. |
Name | For | Votes Withheld | ||||||
Frank J. Bramanti
|
91,755,350 | 11,561,698 | ||||||
Patrick B. Collins
|
88,768,261 | 14,548,787 | ||||||
J. Robert Dickerson
|
88,205,959 | 15,111,089 | ||||||
Walter M. Duer
|
91,649,558 | 11,667,490 | ||||||
Edward H. Ellis, Jr.
|
87,162,974 | 16,154,074 | ||||||
James C. Flagg, Ph.D.
|
90,663,462 | 12,653,586 | ||||||
Allan W. Fulkerson
|
89,443,412 | 13,873,636 | ||||||
John N. Molbeck, Jr.
|
91,755,993 | 11,561,055 | ||||||
James E. Oesterreicher
|
88,947,441 | 14,369,607 | ||||||
Michael A. F. Roberts
|
88,047,759 | 15,269,289 | ||||||
Christopher Williams
|
92,141,009 | 11,176,039 | ||||||
Scott W. Wise
|
92,926,357 | 10,390,691 |
b. | Adoption of the 2008 Flexible Incentive Plan | |
Shareholders were requested to approve the adoption of the 2008 Flexible Incentive Plan. The Plan was approved by the shareholders, who voted as follows: 82,775,829 shares in favor, 14,035,256 against, 89,896 abstained, and 6,416,068 broker non-votes. |
35
c. | Ratification of PricewaterhouseCoopers LLP | |
Shareholders were requested to ratify the appointment of PricewaterhouseCoopers LLP, as our independent registered public accounting firm for the year ended December 31, 2008. Such appointment was approved by the shareholders, who voted as follows: 102,525,426 shares in favor, 761,747 against, and 29,871 abstained. | ||
d. | Vote on Shareholder Proposal | |
Shareholders were requested to vote on a shareholder proposal requesting that management implement equal employment opportunity policies regarding sexual orientation. The proposal was rejected by the shareholders, who voted as follows: 48,828,263 shares in favor, 43,717,873 against, 4,354,846 abstained, and 6,416,067 broker non-votes. For the proposal to pass under Delaware law, the shares in favor must exceed 50% of the total shares present at the meeting, in person or by proxy, and entitled to vote (103,317,049, in this case). | ||
e. | Vote on Shareholder Proposal | |
Shareholders were requested to vote on a shareholder proposal requesting that the Board of Directors initiate a process to amend the Companys bylaws to establish an engagement process with the proponents of shareholder proposals that are supported by a majority of the votes cast, excluding abstentions and broker non-votes. The proposal was rejected by the shareholders, who voted as follows: 20,109,275 shares in favor, 76,503,921 against, 287,785 abstained, and 6,416,068 broker non-votes. |
31.1 | Certification by Chief Executive Officer | |
31.2 | Certification by Chief Financial Officer | |
32.1 | Certification with Respect to Quarterly Report |
36
HCC Insurance Holdings, Inc. | ||
(Registrant) | ||
August 7, 2008
|
/s/ Frank J. Bramanti | |
(Date)
|
Frank J. Bramanti, Chief Executive Officer | |
August 7, 2008
|
/s/ Edward H. Ellis, Jr. | |
(Date)
|
Edward H. Ellis, Jr., Executive Vice President | |
and Chief Financial Officer |
37